Voyager Therapeutics Inc (NASDAQ: VYGR) stock closed at $8.94 on 7/11/24 after a major increase of 10.6%. Moreover, above average trading volume at 139% of normal accompanied the advance. The stock has risen 17.8% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
VYGR’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to be a modest Value Eraser.
Voyager Therapeutics has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Voyager Therapeutics has a poor Appreciation Score of 29 but a slightly positive Power Rating of 69, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment